Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Unexplained biological inflammation (persistently raised CRP without a clue)

Internal medicine and immunology · Abnormal laboratory result · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: About a third of patients investigated for fever or inflammation of unknown origin have inflammation without fever (median 32%) [1]

First-line tests (adult)

Laboratory tests

Imaging

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Do not order

Child: prolonged fever (5 days or more) without a focus

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Do not order

Sources (12)
  1. Betrains A, Moreel L, Mulders-Manders CM, et al. Comparison of diagnostic spectrum between inflammation of unknown origin and fever of unknown origin: A systematic review and meta-analysis. Eur J Intern Med. 2024;124:115-121.
  2. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral (NG12). Mise à jour du 15 avril 2026 : recommandation 1.10.4 (myélome).
  3. Wright WF, Betrains A, Schoenau V, et al. State-of-the-Art Review: Contemporary Ambulatory Approach to Adult Fever of Unknown Origin. Clin Infect Dis. 2026;82(6):909-926.
  4. Riley LK, Rupert J. Evaluation of Patients with Leukocytosis. Am Fam Physician. 2015;92(11):1004-1011.
  5. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : absence d'acte « vitesse de sédimentation » ; acte 4103 (IGRA).
  6. Groupe d'étude français des artérites des gros vaisseaux (GEFA), filière FAI²R. Protocole national de diagnostic et de soins (PNDS) : artérite à cellules géantes (Horton). Haute Autorité de santé, janvier 2024.
  7. Bleeker-Rovers CP, Vos FJ, de Kleijn EMHA, et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86(1):26-38.
  8. Wright WF, Stelmash L, Betrains A, et al. Recommendations for Updating Fever and Inflammation of Unknown Origin From a Modified Delphi Consensus Panel. Open Forum Infect Dis. 2024;11(7):ofae298.
  9. David A, Quinlan JD. Fever of Unknown Origin in Adults. Am Fam Physician. 2022;105(2):137-143.
  10. Chow A, Robinson JL. Fever of unknown origin in children: a systematic review. World J Pediatr. 2011;7(1):5-10.
  11. National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management (NG143). Publiée le 7 novembre 2019, mise à jour le 26 novembre 2021 ; recommandations 1.2.14, 1.2.25, 1.4.4, 1.5.10 et tableau 1 (feu tricolore).
  12. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135(17):e927-e999.